Kelly Lawrence W & Associates’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-33
Closed -$1.91K 165
2023
Q1
$1.91K Hold
33
﹤0.01% 155
2022
Q4
$2.39K Hold
33
﹤0.01% 153
2022
Q3
$2K Hold
33
﹤0.01% 168
2022
Q2
$2K Buy
+33
New +$2.19K ﹤0.01% 170
2017
Q2
Sell
-4,604
Closed -$217K 173
2017
Q1
$217K Hold
4,604
0.04% 86
2016
Q4
$221K Hold
4,604
0.05% 87
2016
Q3
$182K Sell
4,604
-448
-9% -$16.8K 0.04% 92
2016
Q2
$180K Hold
5,052
0.04% 93
2016
Q1
$197K Hold
5,052
0.05% 86
2015
Q4
$217K Hold
5,052
0.05% 86
2015
Q3
$213K Sell
5,052
-2,635
-34% -$123K 0.05% 88
2015
Q2
$384K Hold
7,687
0.08% 70
2015
Q1
$346K Hold
7,687
0.07% 69
2014
Q4
$371K Buy
+7,687
New +$365K 0.08% 66
2014
Q3
Sell
-8,976
Closed -$444K 102
2014
Q2
$444K Sell
8,976
-208,977
-96% -$9.78M 0.09% 63
2014
Q1
$10.3M Sell
217,953
-3,788
-2% -$174K 2.35% 23
2013
Q4
$10.7M Buy
221,741
+55,538
+33% +$2.49M 2.37% 19
2013
Q3
$6.96M Buy
166,203
+7,125
+4% +$307K 1.64% 32
2013
Q2
$6.49M Buy
+159,078
New +$5.85M 1.65% 31

Other funds holding MET

Kelly Lawrence W & Associates's MET Position: Q2 2023 in Review

Kelly Lawrence W & Associates sold out of MetLife (MET) in Q2 2023, closing a stake of 33 shares — an estimated $1.91K sold.

Kelly Lawrence W & Associates first reported a position in MET in Q2 2013 and held it in 19 quarters. The position peaked at $10.7M in Q4 2013. 1,171 funds tracked by Wall St. Rank hold MET as of Q2 2023.

  • Kelly Lawrence W & Associates reported no remaining MetLife position as of Q2 2023 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 33 MetLife shares in Q2 2023, an estimated $1.91K.
  • Kelly Lawrence W & Associates first reported a position in MetLife in Q2 2013 and held it in 19 quarters.
  • Kelly Lawrence W & Associates's MetLife position peaked at $10.7M in Q4 2013.
  • 1,171 funds tracked by Wall St. Rank held MetLife as of Q2 2023.

Based on Kelly Lawrence W & Associates's 13F filing for Q2 2023, filed 14 Aug 2023.